Galapagos NV
A biotechnology company focused on a rapid, decentralized cell therapy platform.
GLPG | BR
Overview
Corporate Details
- ISIN(s):
- BE0003818359
- LEI:
- 549300QKJ78IY0IOV655
- Country:
- Belgium
- Address:
- Industriepark Mechelen Noord, Generaal De Wittelaan L11 A3, 2800 Mechelen
- Website:
- https://www.glpg.com/
- Sector:
- Manufacturing
Description
Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-24 06:29 |
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Acc…
|
English | PDF • 262.1 KB | ||
| 2025-07-24 06:28 |
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Gr…
|
English | PDF • 248.2 KB | ||
| 2025-07-24 06:28 |
Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Ja…
|
Dutch | PDF • 269.0 KB | ||
| 2025-07-24 06:27 |
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter …
|
English | PDF • 354.4 KB | ||
| 2025-07-24 06:27 |
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter …
|
Dutch | PDF • 372.1 KB | ||
| 2025-07-23 22:01 |
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter …
|
English | PDF • 373.8 KB | ||
| 2025-07-23 22:01 |
Galapagos rapporteert halfjaarcijfers 2025 en geeft een update over de activite…
|
Dutch | PDF • 462.5 KB | ||
| 2025-07-23 22:01 |
Galapagos Half-Year report 2025.pdf
|
English | PDF • 3.4 MB | ||
| 2025-07-23 22:01 |
Galapagos Halfjaarverslag 2025.pdf
|
Dutch | PDF • 3.4 MB | ||
| 2025-06-23 08:37 |
Galapagos benoemt Aaron Cox als Chief Financial Officer
|
Dutch | PDF • 280.5 KB | ||
| 2025-06-23 08:37 |
Galapagos benoemt Aaron Cox als Chief Financial Officer
|
English | PDF • 268.4 KB | ||
| 2025-06-23 07:30 |
Galapagos Press Release_CFO_ENG.pdf
|
English | PDF • 268.4 KB | ||
| 2025-06-23 07:30 |
Galapagos Press Release_CFO_NL.pdf
|
Dutch | PDF • 280.5 KB | ||
| 2025-06-19 07:38 |
Company announcement
|
Dutch | PDF • 347.4 KB | ||
| 2025-06-19 07:38 |
Company announcement
|
English | PDF • 314.4 KB |
Automate Your Workflow. Get a real-time feed of all Galapagos NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Galapagos NV
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Galapagos NV via our API.
Peer Companies
